Design and application of prodrug fluorescent probes for the detection of ovarian cancer cells and release of anticancer drug

• Published in: Biosensors & bioelectronics Vol. 236; p. 115401
• Main Authors: Chen, Shijun, Tang, Yangyou, Li, Yiyi, Huang, Mingzhao, Ma, Xiaodong, Wang, Lin, Wu, Yuanyuan, Wang, Yaping, Fan, Wenkang, Hou, Shicong
• Format: Journal Article
• Language: English
• Published: England Elsevier B.V 15.09.2023
• Subjects: Anti-tumor; Fluorescent probe; Prodrug; β-galactosidase; β-galactosidase; Anti-tumor; Prodrug; Fluorescent probe
• ISSN: 0956-5663; 1873-4235
• DOI: 10.1016/j.bios.2023.115401

Ovarian cancer is a gynecologic malignancy with high mortality. The main reason is that it is detected at an advanced stage due to a lack of early diagnosis and treatment. Therefore, it is of great interest to develop a chemical tool that can visualize ovarian cancer cells in real-time and eliminate them. Unfortunately, probes that can simultaneously monitor both modes of action for the diagnosis and treatment of ovarian cancer have not been developed. Here, we designed a novel prodrug fluorescent probe (YW-OAc) that not only visually tracks cancer cells but also enables the on-demand delivery of chemotherapeutic agents. By β-Gal-mediated glycosidic bond hydrolysis, the fluorescent signal changed from blue to green (signal 1), enabling visual tracking of ovarian cancer cells. Subsequently, the identified cancer cells were subjected to precise light irradiation to induce anticancer drug release accompanied by a fluorescence transition from green to blue (signal 2), enabling real-time information on drug release. Thus, the prodrug fluorescent probe YW-OAc provides comprehensive two-step monitoring during cancer cell recognition and clearance. Notably, YW-OAc exhibited high affinity (Km = 3.74 μM), high selectivity, and low detection limit for β-Gal (0.0035 U/mL). We also demonstrated that YW-OAc can visually trace endogenous β-Gal in different cells and exhibit high phototoxicity in ovarian cancer cells. We hope that the prodrug fluorescent probe YW-OAc, can be used as an effective tool for biomedical diagnosis and treatment. •The probe can accurately track endogenous β-Gal in different cells.•The probe can be used for visualization and ablation of ovarian cancer cells.•The probe exhibited high affinity (Km = 3.74 μM), high selectivity, and low detection limit for β-Gal (0.0035 U/mL).